Skip to main content
Premium Trial:

Request an Annual Quote

Life Technologies Plans Share Repurchase

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) - Life Technologies said today that its board has authorized the repurchase of up to $500 million in shares.

The program authorizes the company's management to repurchase shares on the open market or in privately negotiated transactions.

"Given our continued outlook for significant free cash flow generation, we believe the company is in strong financial position to meet both our capital requirements to invest for future growth, while also returning excess cash to shareholders," Gregory Lucier, CEO and chairman of Life Tech, said in a statement.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.